Eminence Capital’s Labcorp LH Stock Holding History

Eminence Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-414,307	Closed	-$100M	–	75
2021 Q3	$100M	Buy	+414,307	New	+$104M	1.35%	32
2021 Q2	–	Sell	-623,994	Closed	-$137M	–	78
2021 Q1	$137M	Sell	623,994 -91,207	-13%	-$18.3M	1.69%	21
2020 Q4	$125M	Buy	715,201 +541,904	+313%	+$93.6M	1.17%	33
2020 Q3	$28M	Buy	173,297 +16,407	+10%	+$2.6M	0.27%	65
2020 Q2	$22.4M	Buy	+156,890	New	+$21.7M	0.22%	68
2014 Q2	–	Sell	-499,233	Closed	-$42.1M	–	67
2014 Q1	$42.1M	Sell	499,233 -222,619	-31%	-$17.8M	0.68%	58
2013 Q4	$56.7M	Buy	721,852 +4,107	+0.6%	+$350K	1%	47
2013 Q3	$61.1M	Buy	717,745 +24,451	+4%	+$2.06M	1.35%	39
2013 Q2	$59.6M	Buy	+693,294	New	+$57.6M	1.46%	33

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eminence Capital's LH Position: Q4 2021 in Review

Eminence Capital sold out of Labcorp (LH) in Q4 2021, closing a stake of 414,307 shares — an estimated $100M sold.

Eminence Capital first reported a position in LH in Q2 2013 and held it in 9 quarters. The position peaked at $137M in Q1 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

Eminence Capital reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
Eminence Capital sold 414,307 Labcorp shares in Q4 2021, an estimated $100M.
Eminence Capital first reported a position in Labcorp in Q2 2013 and held it in 9 quarters.
Eminence Capital's Labcorp position peaked at $137M in Q1 2021.
1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Eminence Capital's 13F filing for Q4 2021, filed 14 Feb 2022.